David Wayne Johnson

Summary

Country: Australia

Publications

  1. ncbi request reprint A randomized controlled trial of topical exit site mupirocin application in patients with tunnelled, cuffed haemodialysis catheters
    David Wayne Johnson
    Department of Renal Medicine, Princess Alexandra Hospital, Brisbane, Australia
    Nephrol Dial Transplant 17:1802-7. 2002
  2. ncbi request reprint Obesity is associated with worsening cardiovascular risk factor profiles and proteinuria progression in renal transplant recipients
    Kirsten A Armstrong
    Department of Nephrology, University of Queens and at Princess Alexandra Hospital, Brisbane, Australia
    Am J Transplant 5:2710-8. 2005
  3. ncbi request reprint Evaluation of renal function - CARI guidelines
    David W Johnson
    University of Queensland, Princess Alexandra Hospital, Brisbane, Queensland, Australia
    Aust Fam Physician 36:46. 2007
  4. pmc The impact of automated eGFR reporting and education on nephrology service referrals
    Euan Noble
    Department of Renal Medicine, University of Queensland, Princess Alexandra Hospital, Woolloongabba, Brisbane Qld 4102, Australia
    Nephrol Dial Transplant 23:3845-50. 2008
  5. doi request reprint Antibacterial honey for the prevention of peritoneal-dialysis-related infections (HONEYPOT): a randomised trial
    David W Johnson
    Australasian Kidney Trials Network, University of Queensland, Brisbane, QLD, Australia Department of Nephrology, Princess Alexandra Hospital, Brisbane, QLD, Australia Translational Research Institute, Brisbane, QLD, Australia Electronic address
    Lancet Infect Dis 14:23-30. 2014
  6. pmc Oral disease in adults treated with hemodialysis: prevalence, predictors, and association with mortality and adverse cardiovascular events: the rationale and design of the ORAL Diseases in hemodialysis (ORAL-D) study, a prospective, multinational, longitu
    Giovanni F M Strippoli
    Department of Clinical Pharmacology and Epidemiology, Consorzio Mario Negri Sud, Italy
    BMC Nephrol 14:90. 2013
  7. pmc A randomised controlled trial of Heparin versus EthAnol Lock THerapY for the prevention of Catheter Associated infecTion in Haemodialysis patients--the HEALTHY-CATH trial
    Jennifer K Broom
    Department of Infectious Diseases, University of Queensland, Nambour General Hospital, PO Box 547, Nambour, QLD, 4560, Australia
    BMC Nephrol 13:146. 2012
  8. pmc The effect of lowering salt intake on ambulatory blood pressure to reduce cardiovascular risk in chronic kidney disease (LowSALT CKD study): protocol of a randomized trial
    Emma J McMahon
    Princess Alexandra Hospital, 199 Ipswich Road, Woolloongabba, Brisbane, QLD, 4102, Australia
    BMC Nephrol 13:137. 2012
  9. pmc Functional significance of erythropoietin in renal cell carcinoma
    Christudas Morais
    Centre for Kidney Disease Research, School of Medicine, University of Queensland at Princess Alexandra Hospital, Building 33, Brisbane, Queensland, 4102, Australia
    BMC Cancer 13:14. 2013
  10. pmc End-stage kidney disease due to haemolytic uraemic syndrome--outcomes in 241 consecutive ANZDATA registry cases
    Wen Tang
    ANZDATA Registry, Adelaide, Australia
    BMC Nephrol 13:164. 2012

Collaborators

Detail Information

Publications102 found, 100 shown here

  1. ncbi request reprint A randomized controlled trial of topical exit site mupirocin application in patients with tunnelled, cuffed haemodialysis catheters
    David Wayne Johnson
    Department of Renal Medicine, Princess Alexandra Hospital, Brisbane, Australia
    Nephrol Dial Transplant 17:1802-7. 2002
    ..Whether mupirocin offers any additional protection against infection in patients with tunnelled, cuffed haemodialysis catheters has not been studied...
  2. ncbi request reprint Obesity is associated with worsening cardiovascular risk factor profiles and proteinuria progression in renal transplant recipients
    Kirsten A Armstrong
    Department of Nephrology, University of Queens and at Princess Alexandra Hospital, Brisbane, Australia
    Am J Transplant 5:2710-8. 2005
    ..BMI was independently associated with proteinuria progression (beta 0.01, p = 0.008) but not with changing eGFR(MDRD.) In conclusion, obesity is common in RTR and is associated with worsening CV parameters and proteinuria progression...
  3. ncbi request reprint Evaluation of renal function - CARI guidelines
    David W Johnson
    University of Queensland, Princess Alexandra Hospital, Brisbane, Queensland, Australia
    Aust Fam Physician 36:46. 2007
    ..This article summarises CARI guidelines on the Evaluation of renal function and is the first in a series of articles on aspects of assessment and management of patients with chronic kidney disease...
  4. pmc The impact of automated eGFR reporting and education on nephrology service referrals
    Euan Noble
    Department of Renal Medicine, University of Queensland, Princess Alexandra Hospital, Woolloongabba, Brisbane Qld 4102, Australia
    Nephrol Dial Transplant 23:3845-50. 2008
    ..The aim of this study was to evaluate the impact of automated laboratory reporting of eGFR on the quantity and quality of referrals to nephrology services in Southeast Queensland, Australia...
  5. doi request reprint Antibacterial honey for the prevention of peritoneal-dialysis-related infections (HONEYPOT): a randomised trial
    David W Johnson
    Australasian Kidney Trials Network, University of Queensland, Brisbane, QLD, Australia Department of Nephrology, Princess Alexandra Hospital, Brisbane, QLD, Australia Translational Research Institute, Brisbane, QLD, Australia Electronic address
    Lancet Infect Dis 14:23-30. 2014
    ....
  6. pmc Oral disease in adults treated with hemodialysis: prevalence, predictors, and association with mortality and adverse cardiovascular events: the rationale and design of the ORAL Diseases in hemodialysis (ORAL-D) study, a prospective, multinational, longitu
    Giovanni F M Strippoli
    Department of Clinical Pharmacology and Epidemiology, Consorzio Mario Negri Sud, Italy
    BMC Nephrol 14:90. 2013
    ..Recent data suggest periodontitis may be associated with mortality in dialysis patients and well-designed, larger studies are now required...
  7. pmc A randomised controlled trial of Heparin versus EthAnol Lock THerapY for the prevention of Catheter Associated infecTion in Haemodialysis patients--the HEALTHY-CATH trial
    Jennifer K Broom
    Department of Infectious Diseases, University of Queensland, Nambour General Hospital, PO Box 547, Nambour, QLD, 4560, Australia
    BMC Nephrol 13:146. 2012
    ..This randomised controlled trial assessed the efficacy of a 48 hour 70% ethanol lock vs heparin locks in prolonging the time to the first episode of catheter related blood stream infection (CRBSI)...
  8. pmc The effect of lowering salt intake on ambulatory blood pressure to reduce cardiovascular risk in chronic kidney disease (LowSALT CKD study): protocol of a randomized trial
    Emma J McMahon
    Princess Alexandra Hospital, 199 Ipswich Road, Woolloongabba, Brisbane, QLD, 4102, Australia
    BMC Nephrol 13:137. 2012
    ..This study aims to investigate the effect of reducing sodium intake on blood pressure, risk factors for progression of CKD and other cardiovascular risk factors in CKD...
  9. pmc Functional significance of erythropoietin in renal cell carcinoma
    Christudas Morais
    Centre for Kidney Disease Research, School of Medicine, University of Queensland at Princess Alexandra Hospital, Building 33, Brisbane, Queensland, 4102, Australia
    BMC Cancer 13:14. 2013
    ..In this mini review, we summarize the current knowledge of the role of EPO in RCC. The available data, either for or against the use of EPO in RCC patients, are equivocal and insufficient to draw a definitive conclusion...
  10. pmc End-stage kidney disease due to haemolytic uraemic syndrome--outcomes in 241 consecutive ANZDATA registry cases
    Wen Tang
    ANZDATA Registry, Adelaide, Australia
    BMC Nephrol 13:164. 2012
    ..The aim of this study was to investigate the characteristics and outcomes of patients receiving renal replacement therapy for end-stage kidney disease (ESKD) secondary to haemolytic uraemic syndrome (HUS)...
  11. doi request reprint Renal services disaster planning: lessons learnt from the 2011 Queensland floods and North Queensland cyclone experiences
    David W Johnson
    Department of Nephrology, University of Queensland at Princess Alexandra Hospital, Brisbane, Queensland, Australia
    Nephrology (Carlton) 18:41-6. 2013
    ..This paper details the responses to the disasters and examines what worked and what lessons were learnt. Recommendations are made for dialysis units in relation to disaster preparedness, response and recovery...
  12. pmc Effect of timing of dialysis commencement on clinical outcomes of patients with planned initiation of peritoneal dialysis in the IDEAL trial
    David W Johnson
    Centre for Kidney Disease Research, University of Queensland at Princess Alexandra Hospital, Brisbane, Australia
    Perit Dial Int 32:595-604. 2012
    ....
  13. ncbi request reprint End-stage renal failure due to amyloidosis: outcomes in 490 ANZDATA registry cases
    Wen Tang
    ANZDATA Registry, Adelaide, SA, Australia
    Nephrol Dial Transplant 28:455-61. 2013
    ..There are few reports regarding the long-term renal replacement therapy (RRT) outcomes of amyloidosis...
  14. pmc The effect of low glucose degradation product, neutral pH versus standard peritoneal dialysis solutions on peritoneal membrane function: the balANZ trial
    David W Johnson
    Department of Renal Medicine, Princess Alexandra Hospital, Brisbane, Australia
    Nephrol Dial Transplant 27:4445-53. 2012
    ..This article reports a secondary outcome analysis of the balANZ trial with respect to peritoneal membrane function...
  15. pmc Association of pre-transplant statin use with delayed graft function in kidney transplant recipients
    Janske Reiling
    Queensland Renal Transplant Service, Princess Alexandra Hospital, Brisbane, Australia
    BMC Nephrol 13:111. 2012
    ..The aim of this study was to determine the relationship between prior statin use in renal transplant recipients and the subsequent risk of delayed graft function...
  16. pmc Weekend compared with weekday presentations of peritoneal dialysis-associated peritonitis
    David W Johnson
    Australia and New Zealand Dialysis and Transplant Registry, Adelaide, Australia
    Perit Dial Int 32:516-24. 2012
    ..The aim of the present study was to examine the effects of weekend compared with weekday presentation on peritonitis outcomes...
  17. pmc The effects of biocompatible compared with standard peritoneal dialysis solutions on peritonitis microbiology, treatment, and outcomes: the balANZ trial
    David W Johnson
    Department of Nephrology, University of Queensland, Brisbane, Australia
    Perit Dial Int 32:497-506. 2012
    ..The present paper reports a secondary outcome analysis of the balANZ trial with respect to peritonitis microbiology, treatment, and outcomes...
  18. doi request reprint A randomized controlled trial of oral heme iron polypeptide versus oral iron supplementation for the treatment of anaemia in peritoneal dialysis patients: HEMATOCRIT trial
    Katherine A Barraclough
    Department of Nephrology, University of Queensland at Princess Alexandra Hospital, Brisbane, Australia
    Nephrol Dial Transplant 27:4146-53. 2012
    ..The aim of this multi-centre randomized controlled trial was to determine the ability of HIP administration to augment iron stores in darbepoetin (DPO)-treated patients compared with conventional oral iron supplementation...
  19. pmc The effects of living distantly from peritoneal dialysis units on peritonitis risk, microbiology, treatment and outcomes: a multi-centre registry study
    Yeoungjee Cho
    Australia and New Zealand Dialysis and Transplant Registry, Adelaide, Australia
    BMC Nephrol 13:41. 2012
    ..The aim of the study was to determine whether distance between residence and peritoneal dialysis (PD) unit influenced peritonitis occurrence, microbiology, treatment and outcomes...
  20. pmc Effects of biocompatible versus standard fluid on peritoneal dialysis outcomes
    David W Johnson
    Department of Nephrology, Princess Alexandra Hospital, Ipswich Road, Woolloongabba, Brisbane, QLD 4102, Australia
    J Am Soc Nephrol 23:1097-107. 2012
    ....
  21. doi request reprint Seasonal variation in peritoneal dialysis-associated peritonitis: a multi-centre registry study
    Yeoungjee Cho
    Australia and New Zealand Dialysis and Transplant Registry, Adelaide, Australia
    Nephrol Dial Transplant 27:2028-36. 2012
    ..The role of seasonal variation in peritoneal dialysis (PD)-related peritonitis has been limited to a few small single-centre studies...
  22. doi request reprint Use of aminoglycosides for peritoneal dialysis-associated peritonitis does not affect residual renal function
    Sunil V Badve
    Australia and New Zealand Dialysis and Transplant Registry, Adelaide, Australia
    Nephrol Dial Transplant 27:381-7. 2012
    ..However, there is limited conflicting evidence that aminoglycosides may accelerate loss of residual renal function (RRF) in PD patients. The aim of this study was to study the effect of aminoglycoside use on slope of decline in RRF...
  23. pmc Cardiac and vascular structure and function parameters do not improve with alternate nightly home hemodialysis: an interventional cohort study
    Carolyn L Van Eps
    Department of Nephrology Princess Alexandra Hospital, Ipswich Rd, Brisbane, 4102, Australia
    BMC Nephrol 12:51. 2011
    ..The effect of alternate nightly home hemodialysis (NHD) on cardiovascular structure and function is not known...
  24. pmc Do aluminium-based phosphate binders continue to have a role in contemporary nephrology practice?
    David W Mudge
    Department of Nephrology, University of Queensland at Princess Alexandra Hospital, Ipswich Road, Woolloongabba, Queensland, Australia
    BMC Nephrol 12:20. 2011
    ..Limited evidence suggests that aluminium bone disease may also be on the decline in the era of aluminium removal from dialysis fluid, even with continued use of aluminium binders...
  25. pmc Rationale and design of the HEALTHY-CATH trial: a randomised controlled trial of Heparin versus EthAnol Lock THerapY for the prevention of Catheter Associated infecTion in Haemodialysis patients
    Jennifer K Broom
    Department of Nephrology, University of Queensland at Princess Alexandra Hospital, Brisbane, Australia
    BMC Nephrol 10:23. 2009
    ..The primary aim of the study is to determine whether weekly instillation of 70% ethanol prevents CRBs compared with standard heparin saline...
  26. pmc Intravenous versus oral iron supplementation for correction of post-transplant anaemia in renal transplant patients
    David W Mudge
    Department of Nephrology, University of Queensland at Princess Alexandra Hospital, Brisbane, Australia
    BMC Nephrol 10:14. 2009
    ....
  27. pmc Adiponectin is associated with cardiovascular disease in male renal transplant recipients: baseline results from the LANDMARK 2 study
    Mohd O Kaisar
    Department of Nephrology Princess Alexandra Hospital, Brisbane, Queensland, Australia
    BMC Nephrol 10:29. 2009
    ..No data exists on the association between adiponectin and CVD in renal transplant recipients (RTR)...
  28. pmc Streptococcal peritonitis in Australian peritoneal dialysis patients: predictors, treatment and outcomes in 287 cases
    Stacey O'Shea
    Australia and New Zealand Dialysis and Transplant Registry, Adelaide, Australia
    BMC Nephrol 10:19. 2009
    ..There has not been a comprehensive, multi-centre study of streptococcal peritonitis in patients on peritoneal dialysis (PD) to date...
  29. pmc Rationale and design of the oral HEMe iron polypeptide Against Treatment with Oral Controlled Release Iron Tablets trial for the correction of anaemia in peritoneal dialysis patients (HEMATOCRIT trial)
    Katherine A Barraclough
    Department of Nephrology, University of Queensland at Princess Alexandra Hospital, Brisbane, Australia
    BMC Nephrol 10:20. 2009
    ....
  30. pmc The role of 25-hydroxyvitamin D deficiency in promoting insulin resistance and inflammation in patients with chronic kidney disease: a randomised controlled trial
    William G Petchey
    Department of Nephrology, University of Queensland at Princess Alexandra Hospital, Brisbane, Australia
    BMC Nephrol 10:41. 2009
    ..Secondary hypotheses will test whether this is associated with decreased inflammation and bone/adipocyte-endocrine dysregulation...
  31. pmc Effect of dialysis modality on survival of hepatitis C-infected ESRF patients
    Bhadran Bose
    Australia and New Zealand Dialysis and Transplant Registry, Adelaide, Australia
    Clin J Am Soc Nephrol 6:2657-61. 2011
    ..The aim of this study was to evaluate the impact of dialysis modality on the survival of HCV-infected ESRF patients...
  32. ncbi request reprint Predictors of decline of residual renal function in new peritoneal dialysis patients
    David W Johnson
    Department of Renal Medicine, University of Queensland at Princess Alexandra Hospital, Brisbane, Queensland, Australia
    Perit Dial Int 23:276-83. 2003
    ..The aim of this study was to prospectively evaluate the risk factors for decline of residual renal function (RRF) in an incident peritoneal dialysis (PD) population...
  33. ncbi request reprint The honeypot study protocol: a randomized controlled trial of exit-site application of medihoney antibacterial wound gel for the prevention of catheter-associated infections in peritoneal dialysis patients
    David W Johnson
    Australasian Kidney Trials Network, University of Queensland, Australia
    Perit Dial Int 29:303-9. 2009
    ....
  34. ncbi request reprint Randomized, controlled trial of topical exit-site application of honey (Medihoney) versus mupirocin for the prevention of catheter-associated infections in hemodialysis patients
    David Wayne Johnson
    Department of Renal Medicine, Level 2, Ambulatory Renal and Transplant Services Building, University of Queensland at Princess Alexandra Hospital, Ipswich Road, Woolloongabba, Brisbane, Queensland 4102, Australia
    J Am Soc Nephrol 16:1456-62. 2005
    ....
  35. doi request reprint Frequencies of hepatitis B and C infections among haemodialysis and peritoneal dialysis patients in Asia-Pacific countries: analysis of registry data
    David W Johnson
    Australia and New Zealand Dialysis and Transplant Registry, Discipline of Public Health, University of Adelaide, Adelaide, Australia
    Nephrol Dial Transplant 24:1598-603. 2009
    ..The aim of the present investigation was to evaluate the rates of hepatitis C virus (HCV) and hepatitis B virus (HBV) infections in peritoneal dialysis (PD) and haemodialysis (HD) patients in the Asia-Pacific region...
  36. doi request reprint Associations of dialysis modality and infectious mortality in incident dialysis patients in Australia and New Zealand
    David W Johnson
    Australia and New Zealand Dialysis and Transplant Registry, Adelaide, Australia
    Am J Kidney Dis 53:290-7. 2009
    ..The aim of the present investigation is to compare rates, types, causes, and timing of infectious death in incident peritoneal dialysis (PD) and hemodialysis (HD) patients in Australia and New Zealand...
  37. pmc Oxpentifylline versus placebo in the treatment of erythropoietin-resistant anaemia: a randomized controlled trial
    David Wayne Johnson
    Australian Kidney Trials Network, School of Population Health, University of Queensland, Brisbane, Australia
    BMC Nephrol 9:8. 2008
    ..The main hypothesis of this study is that Oxpentifylline administration will effectively treat erythropoietin- or darbepoietin-resistant anaemia in chronic kidney disease patients...
  38. ncbi request reprint The effect of obesity on renal transplant outcomes
    David W Johnson
    Renal Transplant Unit, Princess Alexandra Hospital, Brisbane, Australia
    Transplantation 74:675-81. 2002
    ..The present study aimed to evaluate the effect of obesity on renal transplant outcomes in a rigorously screened population...
  39. ncbi request reprint Time-integrated CRP level strongly predicts PD patient outcomes--nice to know, but what should we do about it?
    David W Johnson
    Department of Renal Medicine, University of Queensland at Princess Alexandra Hospital, Brisbane, Australia
    Perit Dial Int 25:234-7. 2005
  40. ncbi request reprint Evidence-based guide to slowing the progression of early renal insufficiency
    D W Johnson
    Department of Renal Medicine, University of Queensland at Princess Alexandra Hospital, Ipswich Road, Woolloongabba, Queensland 4102, Australia
    Intern Med J 34:50-7. 2004
    ..The present paper reviews the available published randomised controlled clinical trials and meta-analyses supporting (or refuting) a role for each of these therapeutic manoeuvres...
  41. ncbi request reprint Elevated white cell count at commencement of peritoneal dialysis predicts overall and cardiac mortality
    David Wayne Johnson
    Department of Renal Medicine, University of Queensland at Princess Alexandra Hospital, Brisbane, Australia
    Kidney Int 67:738-43. 2005
    ..The aim of the present study was to evaluate the prognostic value of WCC in patients commencing peritoneal dialysis (PD)...
  42. pmc Rationale and design of the balANZ trial: a randomised controlled trial of low GDP, neutral pH versus standard peritoneal dialysis solution for the preservation of residual renal function
    David W Johnson
    Department of Renal Medicine, Princess Alexandra Hospital, Brisbane, Australia
    BMC Nephrol 11:25. 2010
    ..The main hypothesis of this study is that neutral pH, low glucose degradation product (GDP) peritoneal dialysis (PD) fluid better preserves residual renal function in PD patients over time compared with conventional dialysate...
  43. ncbi request reprint A comparison of peritoneal equilibration tests performed 1 and 4 weeks after PD commencement
    David W Johnson
    Department of Renal Medicine, University of Queensland at Princess Alexandra Hospital, Brisbane, Australia
    Perit Dial Int 24:460-5. 2004
    ....
  44. doi request reprint Encapsulating peritoneal sclerosis: incidence, predictors, and outcomes
    David W Johnson
    Australia and New Zealand Dialysis and Transplant Registry, Adelaide, South Australia, Australia
    Kidney Int 77:904-12. 2010
    ..The risk of death is relatively low and not appreciably different from that of competing risks for mortality in matched dialysis control patients...
  45. ncbi request reprint Superior survival of high transporters treated with automated versus continuous ambulatory peritoneal dialysis
    David W Johnson
    Australia and New Zealand Dialysis and Transplant Registry, Adelaide, Australia
    Nephrol Dial Transplant 25:1973-9. 2010
    ....
  46. ncbi request reprint Recommendations for the use of icodextrin in peritoneal dialysis patients
    David W Johnson
    Princess Alexandra Hospital, Brisbane, Queensland, Australia
    Nephrology (Carlton) 8:1-7. 2003
    ..This paper reviews the available clinical evidence pertaining to the safety and efficacy of icodextrin and makes recommendations for its use in peritonal dialysis...
  47. ncbi request reprint A peritoneal dialysis patient with fatal culture-negative peritonitis
    David W Johnson
    University of Queensland, Princess Alexandra Hospital, Brisbane, Queensland, Australia
    Nephrology (Carlton) 8:49-55. 2003
    ....
  48. pmc Association of dialysis modality and cardiovascular mortality in incident dialysis patients
    David W Johnson
    Australia and New Zealand Dialysis and Transplant Registry, Adelaide, South Australia, Australia
    Clin J Am Soc Nephrol 4:1620-8. 2009
    ..The aim of the investigation presented here was to compare the rates, causes, and timing of cardiovascular (CV) death in incident peritoneal dialysis (PD) and hemodialysis (HD) patients...
  49. ncbi request reprint Metabolic syndrome in severe chronic kidney disease: Prevalence, predictors, prognostic significance and effects of risk factor modification
    David W Johnson
    Department of Renal Medicine, University of Queensland at Princess Alexandra Hospital, Queensland, Australia
    Nephrology (Carlton) 12:391-8. 2007
    ..However, the prevalence, predictors, prognostic value and treatment of MS in the CKD population have not been rigorously studied...
  50. ncbi request reprint Erythropoiesis-stimulating agent hyporesponsiveness
    David W Johnson
    Department of Renal Medicine, University of Queensland at Princess Alexandra Hospital, Brisbane, Queensland, Australia
    Nephrology (Carlton) 12:321-30. 2007
    ..A practical algorithm for approaching the investigation and management of patients with ESA hyporesponsiveness is also provided...
  51. ncbi request reprint A randomized controlled trial of coiled versus straight swan-neck Tenckhoff catheters in peritoneal dialysis patients
    David W Johnson
    Department of Renal Medicine and Renal Transplant Unit, University of Queensland at Princess Alexandra Hospital, Brisbane, QLD, Australia
    Am J Kidney Dis 48:812-21. 2006
    ..However, a recent Cochrane review recommended the need for a large, well-designed, randomized, controlled trial of straight versus coiled PD catheters because of the paucity and suboptimal quality of previously performed trials...
  52. ncbi request reprint Novel renoprotective actions of erythropoietin: new uses for an old hormone
    David W Johnson
    Department of Renal Medicine, University of Queensland at Princess Alexandra Hospital, Brisbane, Queensland, Australia
    Nephrology (Carlton) 11:306-12. 2006
    ..Gaining further insight into the pleiotropic actions of EPO will hopefully eventuate in much-needed, novel therapeutic strategies for patients with kidney disease...
  53. ncbi request reprint Deceased donor renal transplantation--does side matter?
    David W Johnson
    Queensland Renal Transplant Service, University of Queensland, Princess Alexandra Hospital, Brisbane, QLD, Australia
    Nephrol Dial Transplant 21:2583-8. 2006
    ..The aim of the present study was to determine whether the deceased donor kidney side (left or right kidney) was predictive of subsequent kidney transplant outcomes...
  54. ncbi request reprint Delayed administration of darbepoetin or erythropoietin protects against ischemic acute renal injury and failure
    D W Johnson
    Department of Renal Medicine, University of Queensland at Princess Alexandra Hospital, Brisbane, Australia
    Kidney Int 69:1806-13. 2006
    ..These results reaffirm the potential clinical application of DPO and EPO as novel renoprotective agents for patients at risk of ischemic acute renal failure or after having sustained an ischemic renal insult...
  55. ncbi request reprint Dietary protein restriction as a treatment for slowing chronic kidney disease progression: the case against
    David W Johnson
    Department of Renal Medicine, University of Queensland at Princess Alexandra Hospital, Brisbane, Australia
    Nephrology (Carlton) 11:58-62. 2006
    ..g. renin-angiotensin system blockade, blood pressure reduction and statin therapy)...
  56. ncbi request reprint Automated reporting of GFR--coming soon to a laboratory near you!
    David Johnson
    University of Queensland at Princess Alexandra Hospital, Brisbane, Queensland
    Aust Fam Physician 34:925-31. 2005
    ....
  57. ncbi request reprint Chronic kidney disease--management update
    David W Johnson
    University of Queensland at Princess Alexandra Hospital, Brisbane, Queensland
    Aust Fam Physician 34:915-23. 2005
    ..A recent population study demonstrated that one in every 6 Australian adults has CKD (of which the vast majority are unaware)...
  58. ncbi request reprint What is the optimal fat mass in peritoneal dialysis patients?
    David W Johnson
    Department of Renal Medicine, University of Queensland at Princess Alexandra Hospital, Brisbane, Queensland, Australia
    Perit Dial Int 27:S250-4. 2007
    ....
  59. ncbi request reprint Modification of cardiovascular risk in hemodialysis patients: an evidence-based review
    David W Johnson
    Department of Renal Medicine, University of Queensland at Princess Alexandra Hospital, Brisbane, QLD, Australia
    Hemodial Int 11:1-14. 2007
    ..Large, well-conducted, multicenter randomized-controlled trials in this area are urgently required...
  60. ncbi request reprint Intravenous versus oral iron supplementation in peritoneal dialysis patients
    David W Johnson
    Department of Renal Medicine, University of Queensland at Princess Alexandra Hospital, Brisbane, Queensland, Australia
    Perit Dial Int 27:S255-60. 2007
    ..Emerging new iron therapies such as heme iron polypeptide and ferumoxytol may further enhance the tolerability, efficacy, and ease of administration of iron in PD patients...
  61. ncbi request reprint Oral versus intravenous iron supplementation in peritoneal dialysis patients
    D W Johnson
    Department of Renal Medicine, Princess Alexandra Hospital, Brisbane, Queensland, Australia
    Perit Dial Int 21:S231-5. 2001
    ..Nevertheless, a growing body of evidence suggests that, as has been found for hemodialysis patients, intravenous iron therapy is superior to oral iron supplementation in EPO-treated PD patients...
  62. ncbi request reprint Prevention of progression of kidney disease - CARI guidelines
    David W Johnson
    University of Queensland, Princess Alexandra Hospital, Brisbane, Queensland, Australia
    Aust Fam Physician 36:353. 2007
    ..This article summarises the CARI guidelines on Prevention of progression of kidney disease: diet and miscellaneous factors. Complete CARI guideline detail is available at the web site...
  63. pmc Icodextrin as salvage therapy in peritoneal dialysis patients with refractory fluid overload
    D W Johnson
    Peritoneal Dialysis Unit, Princess Alexandra Hospital, Brisbane 4102, Australia
    BMC Nephrol 2:2. 2001
    ..The aim of this study was to evaluate the ability of icodextrin to alleviate refractory, symptomatic fluid overload and prolong technique survival in PD patients...
  64. ncbi request reprint Obesity is associated with worse peritoneal dialysis outcomes in the Australia and New Zealand patient populations
    Stephen P McDonald
    Australia and New Zealand Dialysis and Transplant Registry, Adelaide, Australia
    J Am Soc Nephrol 14:2894-901. 2003
    ..Such patients should be closely monitored during PD and should be considered for early transfer to an alternative renal replacement therapy if difficulties are experienced...
  65. ncbi request reprint Epidemiology and outcomes of peritonitis in children on peritoneal dialysis in Australasia
    Esmeralda B Bordador
    Queensland Child and Adolescent Renal Service, Royal Children s Hospital and Mater Children s Hospitals, Herston Road, 4029 Herston, Brisbane, Queensland, Australia
    Pediatr Nephrol 25:1739-45. 2010
    ..Further prospective studies are required to determine the most appropriate prophylactic measures and antibiotic regimens for use in pediatric patients...
  66. ncbi request reprint Obesity is a risk factor for peritonitis in the Australian and New Zealand peritoneal dialysis patient populations
    Stephen P McDonald
    ANZDATA Registry, Adelaide, South Australia
    Perit Dial Int 24:340-6. 2004
    ..The aim of the present investigation was to examine the association between body mass index (BMI) and peritonitis rates among incident peritoneal dialysis (PD) patients in a large cohort with long-term follow-up...
  67. ncbi request reprint Impact of obesity on renal transplant outcomes
    Kirsten A Armstrong
    Department of Renal Medicine, University of Queensland at Princess Alexandra Hospital, Brisbane, Queensland, Australia
    Nephrology (Carlton) 10:405-13. 2005
    ..It can be concluded, however, that pre- and posttransplant obesity should be targeted as aggressively as the more well-established cardiovascular risk factors in order to optimize long-term renal transplant outcomes...
  68. ncbi request reprint Predictors of a favourable response to icodextrin in peritoneal dialysis patients with ultrafiltration failure
    Kathryn J Wiggins
    Department of Renal Medicine, University of Queensland at Princess Alexandra Hospital, Woolloongabba, Brisbane 4102, Queensland, Australia
    Nephrology (Carlton) 10:33-6. 2005
    ..The aim of this study was to assess factors that were predictive of an increment in ultrafiltration following the introduction of icodextrin in patients with refractory fluid overload...
  69. ncbi request reprint Predictors of baseline peritoneal transport status in Australian and New Zealand peritoneal dialysis patients
    Markus Rumpsfeld
    Australia and New Zealand Dialysis and Transplant Association Registry, Adelaide, Australia
    Am J Kidney Dis 43:492-501. 2004
    ..Factors that predict peritoneal transport status in peritoneal dialysis (PD) patients are poorly understood. The aim of the present study is to determine these factors in Australian and New Zealand incident PD patients...
  70. pmc Pseudomonas peritonitis in Australia: predictors, treatment, and outcomes in 191 cases
    Brian Siva
    Australia and New Zealand Dialysis and Transplant Registry, University of Adelaide at Queen Elizabeth Hospital, Adelaide, South Australia, Australia
    Clin J Am Soc Nephrol 4:957-64. 2009
    ..Pseudomonas peritonitis is a serious complication of peritoneal dialysis. To date, there as been no comprehensive, multicenter study of this condition...
  71. ncbi request reprint Effect of previously failed kidney transplantation on peritoneal dialysis outcomes in the Australian and New Zealand patient populations
    Sunil V Badve
    Australia and New Zealand Dialysis and Transplant Registry, Adelaide, Australia
    Nephrol Dial Transplant 21:776-83. 2006
    ..The aim of the present study was to compare patient survival, death-censored technique survival and peritonitis-free survival between patients initiating PD after failed renal allografts and those after failed native kidneys...
  72. doi request reprint Recovery of renal function in end-stage renal failure--comparison between peritoneal dialysis and haemodialysis
    James A Macdonald
    ANZDATA Registry, Adelaide, Australia
    Nephrol Dial Transplant 24:2825-31. 2009
    ..The aim of this study was to investigate the effect of dialysis modality on the likelihood, timing and durability of recovery of dialysis-independent renal function...
  73. doi request reprint Review article: Hepatitis B and dialysis
    Matthew Edey
    Department of Renal Medicine, University of Queensland at Princess Alexandra Hospital, Brisbane, Queensland, Australia
    Nephrology (Carlton) 15:137-45. 2010
    ..Prevention and treatment will be discussed, with a specific focus on strategies to improve vaccination response, new therapeutic options and selection of patients for therapy...
  74. ncbi request reprint Higher rate and earlier peritonitis in Aboriginal patients compared to non-Aboriginal patients with end-stage renal failure maintained on peritoneal dialysis in Australia: analysis of ANZDATA
    Wai H Lim
    Renal Unit, Queen Elizabeth Hospital, Adelaide, South Australia, Australia
    Nephrology (Carlton) 10:192-7. 2005
    ..Peritonitis accounts for the bulk of these technique failures, but it is uncertain whether the increased risk of peritonitis in Aboriginal patients was independent of associated comorbid conditions, such as diabetes mellitus...
  75. ncbi request reprint Does uric acid have a pathogenetic role in graft dysfunction and hypertension in renal transplant recipients?
    Kirsten A Armstrong
    Department of Renal Medicine, University of Queensland at Princess Alexandra Hospital, Ipswich Road, Brisbane, Queensland 4102, Australia
    Transplantation 80:1565-71. 2005
    ..Uric acid (UA) may play a pathogenetic role in hypertension and kidney disease. We explored the prevalence of hyperuricemia and the relationship of UA to graft function and hypertension in prevalent renal transplant recipients (RTR)...
  76. ncbi request reprint Predictors of renal recovery in Australian and New Zealand end-stage renal failure patients treated with peritoneal dialysis
    Ann Maree S Craven
    Australia and New Zealand Dialysis and Transplant Registry, Adelaide, Australia
    Perit Dial Int 27:184-91. 2007
    ..The aim of this study was to investigate the factors affecting recovery and durability of dialysis-independent renal function following commencement of peritoneal dialysis (PD)...
  77. doi request reprint Polymicrobial peritonitis in peritoneal dialysis patients in Australia: predictors, treatment, and outcomes
    Katherine Barraclough
    Australia and New Zealand Dialysis and Transplant Registry, Adelaide, Australia
    Am J Kidney Dis 55:121-31. 2010
    ..The study aim was to examine the frequency, predictors, treatment, and clinical outcomes of peritoneal dialysis-associated polymicrobial peritonitis...
  78. ncbi request reprint High membrane transport status on peritoneal dialysis is not associated with reduced survival following transfer to haemodialysis
    Kathryn J Wiggins
    Australia and New Zealand Dialysis and Transplant Registry, Adelaide, Australia
    Nephrol Dial Transplant 22:3005-12. 2007
    ..In this study, we aimed to assess the impact of peritoneal membrane transporter status on patient survival and the likelihood of return to PD following transfer from PD to HD...
  79. ncbi request reprint Silibinin--a promising new treatment for cancer
    Catherine Wing Ying Cheung
    Department of Renal Medicine, University of Queensland at Princess Alexandra Hospital, Brisbane, Queensland, Australia
    Anticancer Agents Med Chem 10:186-95. 2010
    ..The results of these studies may help to more precisely target and dose silibinin therapy to optimise clinical outcomes for oncology patients...
  80. ncbi request reprint Erythropoietin protects against ischaemic acute renal injury
    David A Vesey
    Department of Renal Medicine, University of Queensland at Princess Alexandra Hospital, Brisbane, Australia
    Nephrol Dial Transplant 19:348-55. 2004
    ..The aim of the present study was to determine whether EPO administration is also renoprotective in both in vitro and in vivo models of ischaemic acute renal failure...
  81. ncbi request reprint Predictors, treatment, and outcomes of non-Pseudomonas Gram-negative peritonitis
    Elizabeth M Jarvis
    Australia and New Zealand Dialysis and Transplant Registry, Adelaide, South Australia, Australia
    Kidney Int 78:408-14. 2010
    ..Its cure with antibiotics alone is less likely when multiple organisms are involved...
  82. ncbi request reprint Efficacy and side-effect profile of sevelamer hydrochloride used in combination with conventional phosphate binders
    Joanna M Sturtevant
    Department of Nephrology, Princess Alexandra Hospital, Brisbane, Queensland, Australia
    Nephrology (Carlton) 9:406-13. 2004
    ..However, cost limits its usefulness in many countries. Data assessing its effectiveness and safety in combination with conventional phosphate binders are lacking...
  83. ncbi request reprint Interleukin-1beta induces human proximal tubule cell injury, alpha-smooth muscle actin expression and fibronectin production
    David A Vesey
    Department of Renal Medicine, Princess Alexandra Hospital, Woolloongabba, Brisbane, Queensland 4102, Australia
    Kidney Int 62:31-40. 2002
    ..The aim of the present study, therefore, was to investigate the potentially fibrogenic mechanisms of interleukin-1beta (IL-1beta), a macrophage-derived pro-inflammatory cytokine, on human proximal tubule cells (PTC)...
  84. ncbi request reprint Role of protein kinase C and oxidative stress in interleukin-1beta-induced human proximal tubule cell injury and fibrogenesis
    David A Vesey
    Department of Renal Medicine, University of Queensland at the Princess Alexandra Hospital, Brisban, Queensland, Australia
    Nephrology (Carlton) 10:73-80. 2005
    ..This study investigates some of the mechanisms of action of IL-1beta on the proximal tubule...
  85. ncbi request reprint Baseline and time-averaged fluid removal affect technique survival in peritoneal dialysis in a non-linear fashion
    Kathryn J Wiggins
    Department of Renal Medicine, The University of Queensland at the Princess Alexandra Hospital, Woolloongabba, Queensland, Australia
    Nephrology (Carlton) 12:218-23. 2007
    ..The longevity of peritoneal dialysis (PD) is limited by technique failure and patient mortality. The authors assessed the influence of baseline and time-averaged fluid removal on patient, technique and death-censored technique survival...
  86. ncbi request reprint Free fatty acids are associated with obesity, insulin resistance, and atherosclerosis in renal transplant recipients
    Kirsten A Armstrong
    Department of Renal Medicine, University of Queensland at Princess Alexandra Hospital, Brisbane, Queensland, Australia
    Transplantation 80:937-44. 2005
    ..The aim of this study was to determine the prevalence of IR and the relationships between FFAs, central obesity, and atherosclerosis in a cohort of prevalent RTRs...
  87. ncbi request reprint Proinflammatory and proliferative responses of human proximal tubule cells to PAR-2 activation
    David A Vesey
    1Centre for Kidney Disease Research, University of Queensland Department of Medicine, Princess Alexandra Hospital, Brisbane, QLD 4102, Australia
    Am J Physiol Renal Physiol 293:F1441-9. 2007
    ..In PTC cultures SLIGKV-NH2 initiates proinflammatory and proliferative responses. Trypsinogen expressed within the kidney has the potential to contribute to PAR-2 activation in certain circumstances...
  88. ncbi request reprint Chronic kidney disease and automatic reporting of estimated glomerular filtration rate: revised recommendations
    Timothy H Mathew
    Kidney Health Australia, Adelaide, SA, Australia
    Med J Aust 187:459-63. 2007
    ..The Working Group supports the use of eGFR to assist drug dosing decision making in general practice...
  89. ncbi request reprint Intradermal versus intramuscular hepatitis B vaccination in hemodialysis patients: a prospective open-label randomized controlled trial in nonresponders to primary vaccination
    Katherine A Barraclough
    Department of Nephrology, University of Queensland at Princess Alexandra Hospital, Brisbane, Australia
    Am J Kidney Dis 54:95-103. 2009
    ..Primary hepatitis B virus (HBV) vaccination through the intramuscular (IM) route is less efficacious in dialysis patients than in the general population. Previous studies suggest improved seroconversion with intradermal (ID) vaccination...
  90. doi request reprint Predictors and outcomes of fungal peritonitis in peritoneal dialysis patients
    Rhianna Miles
    Australia and New Zealand Dialysis and Transplant Registry, Adelaide, Australia
    Kidney Int 76:622-8. 2009
    ..Our study shows that fungal peritonitis is a serious complication of peritoneal dialysis and should be strongly suspected in the context of recent antibiotic treatment for bacterial peritonitis...
  91. ncbi request reprint Increased targeting of cardiovascular risk factors in patients with chronic kidney disease does not improve atheroma burden or cardiovascular function
    Nicole M Isbel
    Department of Renal Medicine, Princess Alexandra Hospital, Brisbane, Australia
    Am Heart J 151:745-53. 2006
    ..We studied the efficacy of a MRFI program in CKD...
  92. ncbi request reprint Automated reporting of eGFR: a useful tool for identifying and managing kidney disease
    David W Johnson
    Princess Alexandra Hospital, Brisbane, QLD, Australia
    Med J Aust 190:200-3. 2009
    ..Clinicians should be aware of the strengths, weaknesses and appropriate use of eGFR. Considerable research effort is being directed towards further refinement of eGFR...
  93. pmc Cardiorespiratory fitness is independently associated with 25-hydroxyvitamin D in chronic kidney disease
    William G Petchey
    Department of Nephrology, Princess Alexandra Hospital, Brisbane, Queensland, Australia
    Clin J Am Soc Nephrol 6:512-8. 2011
    ....
  94. doi request reprint Prevention of access-related infection in dialysis
    Katherine A Barraclough
    Department of Nephrology, University of Queensland at Princess Alexandra Hospital, Brisbane, Australia
    Expert Rev Anti Infect Ther 7:1185-200. 2009
    ....
  95. ncbi request reprint The influence of obesity on the development and survival outcomes of chronic kidney disease
    Kathryn J Wiggins
    Department of Renal Medicine, University of Queensland at Princess Alexandra Hospital, Brisbane, Queensland 4102, Australia
    Adv Chronic Kidney Dis 12:49-55. 2005
    ..Possible mechanisms underlying these observed associations will be discussed...
  96. doi request reprint Culture-negative peritonitis in peritoneal dialysis patients in Australia: predictors, treatment, and outcomes in 435 cases
    Magid Fahim
    Australia and New Zealand Dialysis and Transplant Registry, Adelaide, Australia
    Am J Kidney Dis 55:690-7. 2010
    ..The aim of this investigation is to examine the frequency, predictors, treatment, and outcomes of culture-negative PD-associated peritonitis...
  97. ncbi request reprint Thrombin stimulates proinflammatory and proliferative responses in primary cultures of human proximal tubule cells
    David A Vesey
    Department of Renal Medicine, University of Queensland, Princess Alexandra Hospital, Brisbane, Queenlsand, Australia
    Kidney Int 67:1315-29. 2005
    ..The aim of this study was to investigate the proinflammatory and fibroproliferative effects of the coagulation protease thrombin on human proximal tubular cells (PTC) in culture...
  98. ncbi request reprint Interleukin-1beta stimulates human renal fibroblast proliferation and matrix protein production by means of a transforming growth factor-beta-dependent mechanism
    David A Vesey
    Department of Renal Medicine, Princess Alexandra Hospital, Brisbane, QLD, Australia
    J Lab Clin Med 140:342-50. 2002
    ..The fibrogenic and proliferative action of IL-1beta on CF appears not to involve activation of PKC or production of NO but is at least partly TGFbeta-dependent...
  99. ncbi request reprint Potential physiological and pathophysiological roles for protease-activated receptor-2 in the kidney
    David A Vesey
    Centre for Kidney Disease Research, University of Queensland Department of Medicine, Princess Alexandra Hospital, Woolloongabba, Brisbane, Queensland, Australia
    Nephrology (Carlton) 12:36-43. 2007
    ..In this review the potential roles of PAR-2 in the kidney are highlighted and discussed...
  100. doi request reprint End-stage kidney disease due to scleroderma--outcomes in 127 consecutive ANZDATA registry cases
    Brian Siva
    ANZDATA Registry, Adelaide, Australia
    Nephrol Dial Transplant 26:3165-71. 2011
    ..Scleroderma is an uncommon cause of end-stage kidney disease (ESKD) which carries significant morbidity and mortality risks. The aim of this study was to determine the prevalence, treatment and outcomes of scleroderma patients with ESKD...
  101. doi request reprint Enterococcal peritonitis in Australian peritoneal dialysis patients: predictors, treatment and outcomes in 116 cases
    Matthew Edey
    Australia and New Zealand Dialysis and Transplant Registry, Adelaide, Australia
    Nephrol Dial Transplant 25:1272-8. 2010
    ..6%, respectively). Removal of the PD catheter within 1 week of enterococcal peritonitis onset was associated with a lower probability of permanent haemodialysis transfer than later removal (74% vs 100%, P = 0.03)...